Arcadia Biosciences Share Price (NASDAQ: RKDA)

$3.86

▲

0.01

(0.26%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Arcadia Biosciences Stock chart to analyse performance

Arcadia Biosciences Inc Key Stats

Check Arcadia Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.85
Open	$3.9
Market Capitalization	$5.3M
Today's Volume	$5.9K
Revenue TTM	$5.4M
EBITDA	$-6.6M
Earnings Per Share (EPS)	$-5.19
Profit Margin	-139.36%
Quarterly Earnings Growth YOY	0.28%
Return On Equity TTM	-87.94%

Stock Returns calculator for Arcadia Biosciences Stock including INR - Dollar returns

The Arcadia Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Arcadia Biosciences investment value today

Current value as on today

₹1,47,720

Returns

₹47,720

(+47.72%)

Returns from Arcadia Biosciences Stock

₹42,435 (+42.44%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Arcadia Biosciences Stock

-17%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Arcadia Biosciences Stock from India on INDmoney has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Arcadia Biosciences Inc

Name
Holdings %
Name
Holdings %
Mariner Wealth Advisors LLC
1.06%
Vanguard Group Inc
1.03%
Geode Capital Management, LLC
0.94%
State Street Corp
0.89%
UBS Group AG
0.63%
Tower Research Capital LLC
0.14%

Analyst Recommendation on Arcadia Biosciences Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Arcadia Biosciences(by analysts ranked 0 to 5 stars)

Arcadia Biosciences Share Price Target

What analysts predicted

Upside of 210.88%

Target:

$12.00

Current:

$3.86

Arcadia Biosciences share price target is $12.00, a slight Upside of 210.88% compared to current price of $3.86 as per analysts' prediction.

Arcadia Biosciences Stock Insights

Price Movement
In the last 3 years, RKDA stock has moved down by -88.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.2M → 1.45M (in $), with an average increase of 17.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 2.59M → -4.45M (in $), with an average decrease of 271.5% per quarter
RKDA vs K (3 yr)
In the last 3 years, Kellanova has given 8.6% return, outperforming this stock by 96.8%

Arcadia Biosciences Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.2M	↓ 20.15%
Net Income	$-28.9M	↑ 114.19%
Net Profit Margin	-2.5K%	↓ 1549.12%

	FY20	Y/Y Change
Revenue	$8.0M	↑ 587.25%
Net Income	$-6.0M	↓ 79.13%
Net Profit Margin	-75.01%	↑ 2394.88%

	FY21	Y/Y Change
Revenue	$6.8M	↓ 15.61%
Net Income	$-16.1M	↑ 167.74%
Net Profit Margin	-237.96%	↓ 162.95%

	FY22	Y/Y Change
Revenue	$10.0M	↑ 46.84%
Net Income	$-15.6M	↓ 3.24%
Net Profit Margin	-156.81%	↑ 81.15%

	FY23	Y/Y Change
Revenue	$5.3M	↓ 46.46%
Net Income	$-14.0M	↓ 10.45%
Net Profit Margin	-262.31%	↓ 105.5%

	FY24	Y/Y Change
Revenue	$5.0M	↓ 5.35%
Net Income	$-7.0M	↓ 49.66%
Net Profit Margin	-139.5%	↑ 122.81%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.3M	↑ 7.26%
Net Income	$-2.4M	↓ 15.07%
Net Profit Margin	-193.07%	↑ 50.78%

	Q2 FY24	Q/Q Change
Revenue	$1.3M	↑ 4.06%
Net Income	$1.1M	↓ 143.79%
Net Profit Margin	81.24%	↑ 274.31%

	Q3 FY24	Q/Q Change
Revenue	$1.5M	↑ 17.69%
Net Income	$-1.6M	↓ 251.93%
Net Profit Margin	-104.88%	↓ 186.12%

	Q4 FY24	Q/Q Change
Revenue	$1.2M	↓ 20.88%
Net Income	$-4.1M	↑ 152.11%
Net Profit Margin	-334.21%	↓ 229.33%

	Q1 FY25	Q/Q Change
Revenue	$1.2M	↓ 1.32%
Net Income	$2.6M	↓ 163.95%
Net Profit Margin	216.58%	↑ 550.79%

	Q2 FY25	Q/Q Change
Revenue	$1.5M	↑ 21.25%
Net Income	$-4.5M	↓ 271.53%
Net Profit Margin	-306.39%	↓ 522.97%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$284.0K	↓ 64.63%

	FY20	Y/Y Change
Profit	$2.8M	↑ 898.24%

	FY21	Y/Y Change
Profit	$-1.9M	↓ 168.01%

	FY22	Y/Y Change
Profit	$154.0K	↓ 107.99%

	FY23	Y/Y Change
Profit	$2.0M	↑ 1218.18%

	FY24	Y/Y Change
Profit	$2.1M	↑ 2.56%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$435.0K	↓ 13.0%

	Q2 FY24	Q/Q Change
Profit	$673.0K	↑ 54.71%

	Q3 FY24	Q/Q Change
Profit	$505.0K	↓ 24.96%

	Q4 FY24	Q/Q Change
Profit	$389.0K	↓ 22.97%

	Q1 FY25	Q/Q Change
Profit	$518.0K	↑ 33.16%

	Q2 FY25	Q/Q Change
Profit	$631.0K	↑ 21.81%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-17.2M	↑ 26.17%
Investing Cash Flow	$-8.4M	↑ 40.07%
Financing Cash Flow	$22.0M	↓ 2.19%

	FY20	Y/Y Change
Operating Cash Flow	$-30.2M	↑ 75.71%
Investing Cash Flow	$17.3M	↓ 306.52%
Financing Cash Flow	$20.6M	↓ 6.49%

	FY21	Y/Y Change
Operating Cash Flow	$-25.9M	↓ 14.4%
Investing Cash Flow	$16.6M	↓ 3.91%
Financing Cash Flow	$21.9M	↑ 6.52%

	FY22	Y/Y Change
Operating Cash Flow	$-14.0M	↓ 45.97%
Investing Cash Flow	$1.4M	↓ 91.47%
Financing Cash Flow	$4.5M	↓ 79.37%

	FY23	Y/Y Change
Operating Cash Flow	$-15.3M	↑ 9.42%
Investing Cash Flow	$-4.3M	↓ 406.56%
Financing Cash Flow	$5.5M	↑ 21.97%

	FY24	Y/Y Change
Operating Cash Flow	$-9.6M	↓ 37.05%
Investing Cash Flow	$7.3M	↓ 269.01%
Financing Cash Flow	$9.0K	↓ 99.84%

Q1 FY24

Q2 FY24

Q3 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-3.2M	↓ 22.56%
Investing Cash Flow	$4.0K	-
Financing Cash Flow	$5.0K	↓ 100.01%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-2.5M	↓ 23.49%
Investing Cash Flow	$4.6M	↑ 115975.0%
Financing Cash Flow	$0.0	↓ 100.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-1.8M	↓ 28.66%
Investing Cash Flow	$180.0K	↓ 96.12%
Financing Cash Flow	$4.0K	-

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-1.6M	↓ 28.11%
Investing Cash Flow	$500.0K	-
Financing Cash Flow	$5.0K	-

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-2.0M	↑ 28.02%
Investing Cash Flow	$250.0K	↓ 50.0%
Financing Cash Flow	$0.0	↓ 100.0%

Arcadia Biosciences Technicals Summary

Sell

Neutral

Buy

Arcadia Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Arcadia Biosciences Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Arcadia Biosciences Inc	-10.49%	1.29%	42.03%	-88.71%	-96.97%
Jbs Nv	17.99%	16.8%	16.8%	16.8%	16.8%
Kraft Heinz Company, The	1.88%	-10.68%	-21.4%	-25.8%	-18.06%
Mccormick & Company, Incorporated	-0.35%	-16.93%	-13.32%	-16.99%	-31.64%
General Mills, Inc.	0.7%	-20.53%	-32.09%	-36.07%	-21.86%
Kellanova	-0.46%	-3.81%	-0.87%	8.34%	14.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Arcadia Biosciences Inc	NA	NA	-0.08	-2.56	-0.88	-0.33	NA	3.32
Jbs Nv	7.24	7.24	NA	0.0	0.0	0.0	NA	NA
Kraft Heinz Company, The	13.04	NA	1.02	2.6	-0.12	0.04	0.06	34.93
Mccormick & Company, Incorporated	24.52	24.52	2.91	3.05	0.14	0.05	0.02	20.87
General Mills, Inc.	12.03	12.03	11.12	0.0	0.25	0.07	0.05	16.96
Kellanova	20.8	20.8	3.5	3.68	0.35	0.08	0.03	11.82

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Arcadia Biosciences Inc	Buy	$5.3M	-96.97%	NA	-139.36%
Jbs Nv	NA	$15.2B	16.8%	7.24	0.0%
Kraft Heinz Company, The	Buy	$32.7B	-18.06%	13.04	-20.83%
Mccormick & Company, Incorporated	Hold	$18.8B	-31.64%	24.52	11.5%
General Mills, Inc.	Hold	$26.4B	-21.86%	12.03	11.78%
Kellanova	Hold	$27.6B	14.76%	20.8	10.56%

About Arcadia Biosciences Inc

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Organization	Arcadia Biosciences
Employees	9
CEO	Mr. Thomas J. Schaefer C.F.A.
Industry	Process Industries

Key Management of Arcadia Biosciences Inc

Name	Title
Mr. Thomas J. Schaefer C.F.A.	CEO, President & Director
Mr. Mark Kawakami	Chief Financial Officer

Important FAQs about investing in RKDA Stock from India :

What is Arcadia Biosciences share price today?

Arcadia Biosciences share price today is $3.86 as on August 30, 2025 at 1:29 am IST at the close of the market. Arcadia Biosciences share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Arcadia Biosciences share?

Arcadia Biosciences share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Arcadia Biosciences stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.86, lower by 62.56% versus the 52 week high.

How to invest in Arcadia Biosciences Stock (RKDA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Arcadia Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcadia Biosciences Shares that will get you 0.3886 shares as per Arcadia Biosciences share price of $3.86 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Arcadia Biosciences Stock (RKDA) from India?

Indian investors can start investing in Arcadia Biosciences (RKDA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Arcadia Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Arcadia Biosciences share’s latest price of $3.86 as on August 30, 2025 at 1:29 am IST, you will get 2.5907 shares of Arcadia Biosciences. Learn more about fractional shares .

What are the returns that Arcadia Biosciences has given to Indian investors in the last 5 years?

Arcadia Biosciences stock has given -96.97% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?